Skip to main content

Triad Wealth Partners, LLC

Position in LLY — ELI LILLY & Co

CIK 2012717 LAWRENCE, KS

Position in LLY

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$5,164,746
+$1,176,624 QoQ
Shares Held
4,306
-0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#1,683
of 4,605 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$1,079,487
PutShares
900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Triad Wealth Partners, LLC holds $17,358,654 across 10 Drug Manufacturers - General names. LLY ranks #1 (29.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page
4,306 $5,164,746

All Filings in LLY

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,079,487 900
2026-06-30 $5,164,746 4,306
2026-03-31 $3,988,122 4,336
2025-12-31 $2,684,550 2,498
2025-09-30 $887,369 1,163
2025-06-30 $1,079,649 1,385
2025-03-31 $797,829 966
2024-12-31 $657,744 852
2024-06-30 $555,903 614
2024-03-31 $318,185 409